Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 146 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritisHopkins, A.; Wiese, M.; O'Doherty, C.; Proudman, S.; Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association 56th Annual Scientific Meeting (23 May 2015 - 26 May 2015 : Adelaide, South Australia)
2015Measures of disease status in systemic sclerosis: systematic reviewTay, T.; Ferdowsi, N.; Baron, M.; Stevens, W.; Hudson, M.; Proudman, S.; Nikpour, M.; Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting (23 May 2015 - 26 May 2015 : Adelaide, South Australia)
2012Identifying and quantifying prognostic factors in SSc-related interstitial lung disease using a time-varying covariate survival modelMoore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Byron, J.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.; 2nd Systemic Sclerosis World Congress (02 Feb 2012 - 04 Feb 2012 : Madrid, Spain)
2013An immunochip based interrogation of scleroderma susceptibility variantsCharlesworth, J.; Stankovich, J.; Lewis, P.; Byron, J.; Stevens, W.; Sahhar, J.; Proudman, S.; Roddy, J.; Nash, P.; Tymms, K.; Brown, M.; Zochling, J.; 2012 Annual European Congress of Rheumatology (EULAR) (06 Jun 2012 - 09 Jun 2012 : Berlin, Germany)
2012Extent of disease on high-resolution CT lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseMoore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Byron, J.; Sahhar, J.; Roddy, J.; Gabbay, E.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)
2014A pilot study to assess the impact of patient, genetic and disease factors on response to the disease modifying anti-rheumatic drug leflunomideWiese, M.; Hopkins, A.; Spargo, L.; McWilliams, L.; O'Doherty, C.; Cleland, L.; Proudman, S.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2013Anti-phospholipid antibodies in systemic sclerosis: prevalence and clinical correlationsMorrisroe, K.B.; Stevens, W.M.; Byron, J.; Thakkar, V.; Moore, O.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group; 2012 Annual European Congress of Rheumatology (EULAR) (06 Jun 2012 - 09 Jun 2012 : Berlin, Germany)
2012Prevalence and clinical phenotypic associations of anti-Ro52/TRIM21 in an Australian scleroderma cohortTan, J.; Patterson, K.; Proudman, S.; Hakendorf, P.; Roberts-Thomson, P.; Walker, J.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)
2012Idiopathic inflammatory myositis is associated with an increased incidence of systemic sclerosisChaudhary, S.H.; Proudman, S.; Limaye, V.S.; 2012 ACR/ARHP Annual Meeting (09 Nov 2012 - 14 Nov 2012 : Washington, D.C.)
2012Prevalence and correlates of antiphospholipid antibodies in systemic sclerosisMorrisroe, K.; Stevens, W.; Byron, J.; Thakkar, V.; Moore, O.; Proudman, S.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)